KYMR

Kymera Therapeutics (KYMR)

About Kymera Therapeutics (KYMR)

Kymera Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and development of small molecule therapeutics that degrade disease-causing proteins. The company was founded by Bruce Lee Booth and Nello Mainolfi in September 2015 and is headquartered in Watertown, MA.

Details

Daily high

$30.04

Daily low

$29.30

Price at open

$29.79

52 Week High

$53.27

52 Week Low

$19.44

Market cap

1.9B

Dividend yield

0.00%

Volume

452,604

Avg. volume

673,507

P/E ratio

-9.60

Kymera Therapeutics News